T-cell migration is a complex highly coordinated process that involves cell adhesion to the high endothelial venules or to the extracellular matrix by surface receptor/ligand interactions, cytoskeletal rearrangements and phosphorylation-dependent signaling cascades. Mechanism(s) that regulate T-cell migration are of considerable relevance for understanding the pathogenesis of various diseases such as chronic inflammatory diseases and cancer metastasis. This study was designed to identify potential involvement of STAT3, a latent transcription factor, in mediating integrin induced T-cell migration. Using our previously characterized in vitro model for lymphocyte migration, we demonstrate that STAT3 is activated and translocated to the nucleus during the process of active motility of Hut78 T-lymphoma cells triggered via LFA-1. Blocking STAT3 signaling by multiple approaches inhibited LFA-1-induced T-cell locomotion via destabilization of microtubules and post-translational modification of tubulin. Here, we show that STAT3 physically interacts with stathmin to regulate microtubule dynamics in migrating T-cells. These observations strongly indicate that STAT3 is critically important for T-cell migration and associated signaling events.
T-cell migration is a complex highly coordinated process that involves cell adhesion to the high endothelial venules or to the extracellular matrix by surface receptor/ligand interactions, cytoskeletal rearrangements and phosphorylation-dependent signaling cascades. Mechanism(s) that regulate T-cell migration are of considerable relevance for understanding the pathogenesis of various diseases such as chronic inflammatory diseases and cancer metastasis. This study was designed to identify potential involvement of STAT3, a latent transcription factor, in mediating integrin induced T-cell migration. Using our previously characterized in vitro model for lymphocyte migration, we demonstrate that STAT3 is activated and translocated to the nucleus during the process of active motility of Hut78 T-lymphoma cells triggered via LFA-1. Blocking STAT3 signaling by multiple approaches inhibited LFA-1-induced T-cell locomotion via destabilization of microtubules and post-translational modification of tubulin. Here, we show that STAT3 physically interacts with stathmin to regulate microtubule dynamics in migrating T-cells. These observations strongly indicate that STAT3 is critically important for T-cell migration and associated signaling events.
Efficient operation of the adaptive immune system requires migration of T-lymphocytes from the vascular compartment across tissue barriers and through the extracellular matrix. This process involves a series of integrin ligand-receptor interactions (1) that initially retards lymphocyte flow and ultimately leads to arrest and diapedesis across the endothelium (2, 3) . T-cells utilize the integrin, lymphocyte function-associated antigen-1 (LFA-1) 3 when migrating in response to chemoattractants across the vasculature into lymph nodes or inflamed tissues (1, 4, 5) . By engagement with ligands from intercellular adhesion molecule group (ICAMs), and in particular ICAM-1, LFA-1 also provides a strong adhesive force to promote and stabilize T-cell and antigen-presenting-cell conjugate formation. We have demonstrated that LFA-1 transduces a variety of transmembrane signals in crawling T-cells involving protein kinase C activation and cytoskeletal rearrangement (4, (6) (7) (8) (9) . However, the exact sequence of downstream integrin-mediated signaling events resulting in cytoskeletal rearrangements and cell locomotion is not fully understood.
T-cell migration involves cross-talk between integrins and the cytoskeleton, coordinated changes in the cytoskeleton and the controlled formation and dispersal of adhesion sites (10) . Motile lymphocytes develop trailing extensions which contain cytoskeletal and signaling elements (11) . Microtubules (MTs) are essential components of the cytoskeleton and are important for many aspects of mammalian cell responses including cell division, growth, migration and signaling (12) (13) (14) . Whereas the actin cytoskeleton provides the driving force at the cell front, the MT network assumes a regulatory function in coordinating rear retraction (15) . MT retraction into the cellular uropod is an important step in Tcell motility (4, 8) . MTs are necessary for directed migration of multiple cells, and there are several possible mechanisms by which disruption or interference of MTs could block cell motility. These include impairment of the repositioning of the microtubule organizing center (MTOC), changes in MT interaction with focal adhesions, inhibition of MT polymerization and depolymerization cycle, inhibition of intracellular protein trafficking and vesicle transport, and interference with MT-mediated integrin clustering and increased avidity (16) . The reorganization of MT cytoskeleton depends on the global and local activity of several proteins that affect nucleation dynamics and arrangement of the filament systems. Tubulins, the building block of MTs, are subject to specific post-translational modifications including acetylation, detyrosination and tyrosination (13, 17) which potentially modulate the functions and localization of MTs within the cell.
The signal transducers and activators of transcription (STATs) are a family of latent cytoplasmic transcription factors that are activated by many cytokines and growth factors (18) . The STAT family is comprised of seven members in mammals of which STAT3 is the most pleiotropic member (18) (19) (20) and appears to have important and unique functions. Cell stimulation can activate STAT family members by tyrosine phosphorylation to induce their dimerization; activated STAT3 translocates from the cytosol to the cell nucleus to mediate transcription of a number of STAT3-responsive genes (21) . STAT3 was originally identified as a mediator of the acute phase of inflammatory response triggered by interleukin-6 (22) . However, it is now known that STAT3 is implicated in several biological processes including cell proliferation, differentiation, and survival (18-20, 23, 24) . While, STAT3 knockout in mice caused early embryonic lethality (25) , conditional gene targeting using the Cre-loxP strategy has revealed a critical role for STAT3 in cell migration in keratinocytes (23, 26) .
The 18 kDa phosphoprotein stathmin, (also known as oncoprotein 18), is a tubulin binding protein involved in the control of MT assembly and dynamics (27) (28) (29) (30) . Originally identified as a key factor in cell proliferation, it also plays likely roles as a relay protein and integrating protein within intracellular signaling networks (31). Stathmin's inhibitory effect on MT growth is believed to derive from its ability to sequester tubulin by binding tubulin dimers, which decreases the concentration of free heterodimers available to polymerization (20, 30) . The MTdestabilizing activity of stathmin is turned-off by cell surface receptor kinase cascades and cyclindependent kinases (32) . By changing MT polymerisation/depolymerization dynamics stathmin may help the cell react to external stimuli. A recent study has suggested a functional link between stathmin and STAT3; whereby STAT3 interacts with stathmin and antagonizes its MT depolymerization activity (33) .
Here, we report a role for STAT3 in LFA-1 induced T-cell migration. Upon LFA-1 crosslinking, STAT3 is activated by tyrosine phosphorylation that translocates to the nucleus and interacts with stathmin to regulate MT dynamics in migrating T-cells.
EXPERIMENTAL PROCEDURES Antibodies and Reagents -Antibody used for induction of T-cell motility as previously described (8) was of the motility-inducing clone SPVL7 (mAb to the α-chain of LFA-1 from Monosan, Sanbio, Uden, The Netherlands). Rabbit
anti-GAPDH, horseradish peroxidase conjugated anti-rabbit and anti-mouse antibodies were from Cell Signaling Technology (Danvers, MA). Mouse monoclonal anti-α-tubulin, anti-acetylated tubulin (clone 6-11B-1), antityrosinated tubulin (TUB-1A2) and goat antihuman IgG (Fc specific) antibodies were from Sigma (St Louis, MO). Goat anti-mouse IgG was from Dako A/S (Denmark). Human rICAM-1 was from R&D Systems (Minneapolis, MN). Alexa fluor-488 conjugated anti-mouse antibody and Alexa fluor-546 Phalloidin were from Molecular Probes (Invitrogen Corporation, California). Cell permeable AG490 was obtained from Calbiochem (California).
Cell Culture -The human cutaneous Tlymphoma cell line Hut78 [American Type Culture Collection (ATCC), Manassas, VA] was used and cultured as described previously (4) . Briefly, cells were cultured in RPMI 1640 medium (Gibco BRL, Grand Island, NY) containing 10% (v/v) heat inactivated fetal bovine serum, Lglutamine 2 mM , and antibiotics (penicillin 100 IU/ml, streptomycin 100 µg/ml) in a humidified chamber at 37ºC containing 5% CO 2 .
Induction of Cell Motility -The ability of Tcells to display integrin-induced locomotory behaviour was determined using our well characterized migration-triggering model system as previously described (4) . Briefly, 6-or 96-well tissue culture plates (flat bottom, Nunc TM ), depending on the particular assay type were pre-coated with goat anti-mouse IgG or mouse antihuman Fc and subsequently incubated with crosslinking monoclonal motility inducing anti-LFA-1 antibody or human rICAM-1. As a control (resting cells), wells were coated with poly-L lysine (cells adhered to this surface without activation). Hut78 cells were loaded into the coated wells (60 x 10 4 cells/well in 6-well plate or 1.0 x 10 4 cells/well in 96-well plate) and incubated in 5% CO 2 at 37ºC for indicated time periods depending on the particular experiments.
Deformation Index (DI) -In order to quantify migratory phenotype of T-cells, DI was calculated as described previously (3) . DI provides a stronger measure of the degree of cell polarization in comparison to elongation index and circularity alone and therefore more accurately reflects the phenotype of polarized locomotory cells. Typically, values of 1-3 are assigned to cells that were non-migratory, i.e. cell shape nearing circular. Those cells that display a polarized phenotype (cell body and trailing uropod) and therefore a higher degree of deformation will have higher DI values (>5) (17) . On average, >40 randomly chosen cells were scored for each set of conditions.
Semi-automated analysis was performed using the Scion Image software (Scion Corporation, Fredrick, MC).
Cell Lysis, Immunoprecipitation and Immunoblotting -The cell lysis was performed as described previously (34) . The protein content of the cell lysates was determined by Bio-Rad protein assay kit according to manufacturer's instructions (Bio-Rad Laboratories GmbH, München, Germany). Equal amounts of pre-cleared lysates were subjected to immunoprecipitation with antibodies to STAT3, α-tubulin or stathmin as described previously (35) . The cell lysates or immunoprecipited samples were boiled with Laemmli sample buffer for 5 min and resolved by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were electrophoretically transferd to polyvinylidene fluoride (PVDF) membrane by semi-dry blotting for 1 h. The PVDF membranes were blocked in 5% non-fat dry milk in PBST [0.1% (v/v) Tween20 in phosphate buffered saline (PBS)] for 1 h at room temperature. After washing, the blots were incubated with the indicated primary antibodies (diluted according to manufacturer's instructions) overnight at 4ºC with gentle rocking. After three washing in PBST, the membranes were incubated with appropriate horseradish peroxidase conjugated secondary antibodies for 1 h at room temperature. The immunoreactive bands were visualized using the enhanced chemiluminescence detection system (Amersham, Arlington Heights, IL) and subsequent exposure to Kodak light sensitive film (Cedex, France).
STAT Activation Assay using High Content Analysis (HCA) -Serum starved Hut78 cells (10,000 cells per well in 100 µl medium) were seeded in to 96 well tissue culture plates precoated with anti-LFA-1, ICAM-1 or poly L-lysine. Cells were incubated for different time periods depending on particular experiments, fixed and stained with Cellomics® HCS reagent kit for STAT activation as per manufacturer's instructions (Thermo Fisher Scientific Inc.). Plates were scanned (three randomly selected fields per well containing at least 300 cells) using automated microscope (IN Cell Analyzer 1000 HCA platform, GE Healthcare, Buckinghamshire, England). Images were acquired using 20X objective. STAT activation was measured and analyzed by IN Cell Investigator software using nuclear trafficking analysis module (GE Healthcare) that quantifies nuclear to cytoplasmic fluorescence intensity.
Peptide Synthesis -Peptides were synthesized on an Applied Biosystems (Model 433A) peptide synthesizer (Foster City, CA) following standard 9-fluorenylmethoxycarbonyl (Fmoc) amino acid chemistry (36) , using HBTU/HOBt/DIEA as coupling reagents. All Fmoc protected amino acids and coupling reagents were purchased from Novabiochem (Darmstadt, Germany), except Fmoc-protected phosphotyrosine derivative, which was from Bachem (Bachem Distribution Services GmbH, Weil am Rhein, Germany), with phosphate diprotected by (methyldiphenylsilyl)ethyl moiety (37) . Peptides were cleaved from the polymer support and freed from side chain protections in trifluoroacetic acid/triisopropylsilane/water (95/2.5/2.5 in volume) for 4 h. After removing the resin polymer, the peptides were precipitated in cold ether and purified by semi-preparative reversed-phase HPLC on a C18 column (Vydac, 5 µm, 10*250 mm). The molecular weights of peptides were confirmed by mass spectrometry Immunofluorescent Staining and Microscopy -Immunostaining was performed as previously described (4) . Conventional phase contrast microscopy was performed on a Nikon TE3000 inverted microscope (Nikon, Tokyo, Japan) equipped with Leica DC 100 digital camera. Fluorescence microscopy was performed by Zeiss confocal workstation attached to Zeiss LSM 510 laser module using 63X objective (Carl Zeiss, Thornwood, NY). Images were acquired and processed using Zeiss LSM 510 (release 4.0) software (Carl Zeiss). At least 20 different microscopic fields were observed for each sample. Semi-automated analysis for MT fibre length was performed using the Zeiss LSM Image Examiner software (Carl Zeiss).
Cell Viability Assay -Cell viability was measured by CellTiter 96® AQ ueous One Solution cell proliferation assay kit according to the manufacturer's instructions (Promega, Madison, WI). Hut78 cells were distributed in 96-well microplates (1.5 × 10 4 cells/well) in 100 µl of medium and pre-treated with indicated inhibitors. Cells were then incubated with 20 µl of MTS tetrazolium solution (provided by the manufacturer) for an additional 4 h. The relative cell viability was calculated by determining the absorbance at 490 nm using micro-plate reader (Tecan, Mannedorf, Switzerland).
Cell adhesion Assays -Cell adhesion assay was performed as described previously (38) with minor modifications. Briefly, Untreated or pretreated Hut78 cells (1.5 × 10 4 cells in 100 µl of medium) were added to the wells of anti-LFA-1 coated 96-well microtiter plate (as described above). The cells were then incubated for 1 h at 37°C. Non-adherent cells were removed by gentle washing three times with PBS and fixed with 1% glutaraldehyde, 0.5% sucrose in PBS for 15 min at room temperature. After two washes with PBS, the cells were stained with 0.5% crystal violet in 20% methanol/PBS for 30 minutes at room temperature. The cells were then washed five times with PBS and the cell-bound stain was resolubilized in methanol. Cell adhesion was quantified by measuring the absorbance at 590 nm using microplate reader (Tecan).
Densitometric Analysis -Densitometric analyses of the western blots were performed as described previously (34) using GeneTools software (Syngene, Cambridge, UK). The relative values of the samples were determined by giving an arbitrary value of 1.0 to the respective control samples of each experiment.
Statistical Analysis -The data are expressed as mean ± S.E.M. For comparison of two groups, p-values were calculated by two-tailed unpaired student's t-test. In all cases p < 0.05 was considered to be statistically significant. RESULTS
T-Cell Motility Induced by LFA-1 Crosslinking Involves Activation of STAT3 -In resting
Hut78 cells, STAT3 was present mainly in the cytoplasm (Fig. 1A) . Following LFA-1 crosslinking via immobilized anti-LFA-1, cytoplasmic STAT3 translocated into the nucleus within 10 min (Fig. 1A ). Quantitation of STAT3 nuclear translocation showed up to 42.8% increase in 10 min (Fig. 1A ). This increase in STAT3 nuclear translocation was transitory, returning to basal level after 30 min (Fig. 1A) . A similar STAT3 activation profile was observed when cells were incubated on immobilized ICAM-1 (Fig. 1A) . No significant change in the activation of other STAT isoforms STAT1 or STAT2 was observed following LFA-1 cross linking either via immobilized anti-LFA-1 or ICAM-1 to the Hut78 cells ( Supplementary Fig. 1 ).
Next, we sought to determine whether LFA-1 signalling induced tyrosine phosphorylation of STAT3 in Hut78 cells. Following LFA-1 cross linking in Hut78 cells via immobilized anti-LFA-1 or ICAM-1, a greater than 7-fold increase in tyrosine phosphorylation of STAT3 (Tyr705) was observed in 10 min declining towards base line level after 30 min (Fig. 1B) . In contrast, T-cell receptor (TCR) activation by anti-CD3 induced tyrosine phosphorylation of STAT3 showed a distinctly different activation pattern; detected at 10 min that remained constant for up to 4 h (Fig.  1B) . However, CD3 ligation via immobilized anti-CD3 did not induce migration of Hut78 cells up to 4 h (data not shown). Therefore, for further experiments on migrating T-cells, LFA-1 crosslinking of Hut78 cells was employed. No change in the expression of STAT3 protein was observed during these time periods (Fig. 1B) . Together, these results demonstrate that signaling through LFA-1 in Hut78 cells induces changes associated with STAT3 functional activation including nuclear translocation and tyrosine phosphorylation.
Suppression of STAT3 Activity Attenuates LFA-1 Induced T-Cell Polarization and Migration -Hut78 cells triggered via LFA-1 receptor/ligand interaction rapidly polarize and develop a locomotion-associated phenotype (4, 8) . To further investigate the role of STAT3, selective inhibitory strategies were utilized. Initially we used AG490, a Janus kinase specific inhibitor which subsequently reduces STAT3 tyrosine phosphorylation. Hut78 cells were pretreated with different concentrations of AG490 ranging from 1 to 10 µM for 1 h and incubated on anti-LFA-1 coated 96-well plates for 4 h. (Fig. 2A) . Pretreatment of Hut78 cells with AG490 resulted in dose-dependent inhibition of the LFA-1-induced locomotion-associated phenotype ( Fig. 2A) . Quantitation of the observed inhibitory effect of AG490 on motile phenotype of Hut78 cells demonstrated that DI reduced from 7.9 in controls cells to 1.8 when cells were treated with 10 µM AG490 ( Fig. 2A) . Pretreatment of Hut78 cells with 10 µM AG490 also inhibited LFA-1 induced tyrosine phosphorylation of STAT3 (Fig 2B) . AG490 treatment had no significant affect on Hut78 cell survival (Supplementary Fig. 2A ) or adhesion to anti-LFA-1 coated plates ( Supplementary Fig. 2B ). We extended these studies using cell permeable isoform-specific inhibitory peptide specifically targeted against STAT3. This 12-mer phosphopeptide (AYRNRpYRRQYRY), identified through combinatorial chemistry (39) , binds with high affinity and specificity to STAT3 in a BiaCore competition assay. This peptide was conjugated, with a spacer 6-aminohexanoic (Ahx), to a cellpermeable peptide sequence called penetratine or Antennapedia (RQIKIWFQNRRMKWKK), a vector that has been shown to be highly efficient for delivering bioactive molecules (40, 41) . Antennapedia peptide (Antp) alone was used as a control peptide. Hut78 cells were pretreated with a range of concentrations of STAT3 inhibitory peptide (pY-pept) for varying time points ranging from 1 to 12 h. Pretreatment of cells with pY-pept inhibited LFA-1 induced cell migration in a timeand dose-dependent manner (Fig. 3A) . Complete loss of locomotion-associated phenotype was observed at 25 µg/ml concentration of pY-pept treated at least for 4 h (Fig. 3A) . Control untreated or cells treated with non-specific peptide Antp displayed a polarized and elongated morphology when triggered via LFA-1 with DI 8.1 or 7.8 respectively; whereas cells treated with 25 µg/ml pY-pept for 4 h were almost round with DI 1.78 (Fig. 3B) . However, the attachment of cells and formation of associated filopodia remained intact in these cells (data not shown). Pretreatment of Hut78 cells with pY-pept treatment had no significant affect on cell survival ( Supplementary  Fig. 3A ) or adhesion to anti-LFA-1 coated plates ( Supplementary Fig. 3B ). Therefore, for further experimentations short pretreatment of the cells for 4 h with 25 µg/ml concentration of pY-pept was employed. Hut78 cells pretreated with pYpept did not show LFA-1 induced STAT3 tyrosine phosphorylation (Fig 3C) . Use of siRNA-mediated approaches was constrained by the capacity of STAT-3 specific siRNA to induce apoptosis in transfected cells (unpublished data).
Further, to determine if the failure of STAT3 inhibited cells to develop a migratory phenotype was also accompanied by the loss of active locomotion, HCA experiments utilizing time-lapse video imaging by IN Cell Analyzer 1000 automated microscope were performed. A slow and apparently random mode of locomotion was observed in control Hut78 cells triggered via cross-linking of LFA-1. Measuring live cell migration over a period of 20 min gave a clear evidence that pY-pept treatment significantly decreased LFA-1 stimulated Hut78 cells migration (Fig. 3D, E) . Average speed of Hut78 cell migration was recorded to be 1.055 µm/minute which was decreased by 73.1 % (0.283 µm/minute) when were pre-treated with pY-pept (Fig 3D) . Average distance traveled by control cells was 21.1 µm (ranging from 8.3 to 69.5 µm), which was decreased to 6.2 µm (ranging from 0.1 to 22 µm) when cells were pre-treated with pYpept (Fig. 3E) . These findings clearly demonstrate the requirement of active STAT3 function for Tcell locomotion in a physiological microenvironment.
Inhibition of STAT3 Affects MTs of T-CellsWe have recently demonstrated that MT targeting agents such as paclitaxael (a tubulin stabilizer), nocodazole or PBOX-15 (tubulin depolymerizers) inhibited T-cell migration (34) . To determine whether inhibition of STAT3 by pY-pept affects MTs of T-lymphocytes causing inhibition of cell migration, intracellular distribution and functional involvement of the MTs were analyzed. Control untreated Hut78 cells or cells treated with nonspecific peptide Antp showed radial arrays of organized tubulin distribution (Fig. 4A, C) . LFA-1 induced migrating T-cells displayed the characteristic array of MT in that MTOC was located at the side of the nucleus opposing the direction of cell migration and long MT extended to the uropods from here (Fig. 4B, D) . In contrast, exposure of Hut78 cells to STAT3 inhibitory peptide pY-pept dramatically impaired the tubulin network (Fig. 4E ) resulting in complete loss of the typical motile phenotype upon LFA-1 cross linking (Fig. 4F) . Quantitative analysis of the α-tubulin cytoskeletal phenotypes in the population of cells by IN Cell Investigator HCA software (GE Healthcare) indicated that inhibition of STAT3 activity by pY-pept significantly reduced the number of cells (up to less than 8%) with organized MTs (Fig. 4G) . Semi-automated analysis for MT fibre length of 10 randomly selected cells by Zeiss LSM Image Examiner (Carl Zeiss) indicated that pY-pept treatment significantly reduced the average length of tubulin fibre from greater than 11.5 µm to less than 0.5 µm (Fig. 4H ). STAT3 inhibitory peptide did not significantly affect the actin cytoskeletal network ( Supplementary Fig. 4) .
Inhibition of STAT3 Activity Affects Posttranslational Modifications of Tubulin in T-Cells -α-Tubulin
undergoes post-translational modifications including acetylation and tyrosination that are thought to modulate MT stability and dynamics within the cell (13) . To further explore the effect of STAT3 inhibition on post-translational modification of tubulin in migrating T-cells, we examined the total expression of α-tubulin, acetylated α-tubulin and tyrosinated α-tubulin by Western immunoblotting and with densitometric quantitation normalized for GAPDH expression (Fig. 5 ). Acetylated α-tubulin level in LFA-1 stimulated Hut78 cells was 57% lower as compared with resting cells (Fig. 5B ; open bars, lanes 2 vs 1). Pretreatment of cells with pY-pept reduced acetylated tubulin level to 51% ( Fig. 5B ; open bars, lanes 5 vs 1), which was further reduced to 11% after LFA-1 cross linking as compared to control untreated resting cells ( Fig.  5B; open bars, lanes 6 vs 1) . No significant change in the level of acetylated tubulin was observed when Hut78 cells were pretreated with nonspecific peptide Antp ( Fig. 5B ; open bars, lanes 3 vs 1 and 4 vs 2). Tyrosinated tubulin level in migrating Hut78 cells was increased up to 47% compared to the resting cells ( Fig. 5B; closed bars,  lanes 2 vs 1) . Treatment of these cells with pYpept reduced the level of tyrosinated tubulin by 51% in resting ( Fig. 5B; closed bars, lanes 5 vs 1) and by 56% upon LFA-1 cross linking as compared to control (untreated) cells ( Fig. 5B;  closed bars, lanes 6 vs 1) . No significant change in the level of tyrosinated tubulin was observed when Hut78 cells were pretreated with non-specific peptide Antp ( Fig. 5B; closed bars, lanes 3 vs 1  and 4 vs 2) .
Next, to explore the possibility (if any) whether STAT3 exerts its effect on MT assembly and post-translational modification of tubulin by direct physical association with tubulin, cell lysates of resting or LFA-1 stimulated Hut78 cells were immunoprecipitated with tubulin and probed with anti-STAT3 antibody. However, we did not detect STAT3 protein in tubulin immunoprecipitated samples (Data not shown).
STAT3 Exerts Its Effect on MT via
StathminThe spatial organization of the MT cytoskeleton is thought to be directed by several regulatory molecules. Stathmin-tubulin interaction is known to regulate MT dynamics in motile and mitotic cells (28) . Stathmin is known to undergo serine phosphorylation at S16 upon cell stimulation (27) . However, we did not detect stathmin phosphorylation (S16) due to LFA-1 cross-linking ( Fig. 6A; lanes 2 vs 1) . In contrast, CD3 crosslinking induced stathmin phosphorlyation on S16 ( Fig. 6A; lanes 5 vs 1) . Moreover, CD3 induced stathmin phosphorylation was not affected by pYpept (Fig 6A; lanes 7 vs 5) . Microscopic examination of stathmin indicated its cytoplasmic distribution in the resting Hut78 cells (Fig. 6H-J) . Upon LFA-1 stimulation, STAT3 underwent tyrosine phosphorylation and nuclear translocation ( Fig 6B-G) ; however, stathmin remained in the cytoplasm but displayed polarized staining which was not affected by pY-pept treatment (Fig 6H-J) . Phosphorylation (S16) of stathmin was not detected in resting or LFA-1 stimulated Hut78 cells (Fig 6K-M) but was detected in response to stimulation with anti-CD3 (Fig 6A) .
Next, we examined whether stathmin physically interacts with α-tubulin in T-cells (Fig. 7A) . Results showed that stathmin binding to tubulin was reduced to 43% in migrating cells as compared to non-migrating cells (Fig. 7A) . There was no change in the expression of total stathmin protein in resting and LFA-1 stimulated cells as detected by immunoblotting for whole cell lysates (Fig.  7A) . Phospho-stathmin was not detected either in α-tubulin immunoprecipitated samples or in whole cells lysates (Fig. 7A) .
To determine whether STAT3 exerts its effect on MT via stathmin in migrating T-cells, we immunoprecipitated resting and LFA-1 stimulated Hut78 cells with anti-STAT3 or isotype control IgG and probed with anti-stathmin (Fig 7B) . Interestingly, stathmin co-immunoprecipitated with STAT3, with substantially greater amount (3.6 fold) of stathmin co-immunoprecipitated in migrating cells as compared to resting cells (Fig.  7B ). Phospho-stathmin was not detected either in STAT3 immunoprecipitated samples or in whole cells lysates (Fig. 7B) .
Similarly, untreated or pY-pept treated resting and LFA-1 stimulated Hut78 cells were immunoprecipitated with anti-stathmin or isotype control IgG and probed for the presence of STAT3, pSTAT3 or α-tubulin. A 3.8 fold higher association between stathmin and STAT3 was observed in LFA-1 induced samples as compared to resting cells (Fig. 7C) . Pre-treatment of Hut78 cells with pY-pept inhibited STAT3 -stathmin association (Fig. 7C ). Stathmin association with pSTAT3 was increased to 5 fold in LFA-1 stimulated Hut78 cells as compared to resting cells (Fig. 7C) . pSTAT3 was not detected in pY-pept treated samples (Fig. 7C) .
α-Tubulin coprecipitated with stathmin in both the resting and LFA-1 induced samples. Association of α-tubulin with stathmin reduced to 0.57 fold in LFA-1 stimulated Hut78 cells as compared with resting cells (Fig. 7C) . This decrease in α-tubulinstathmin association in LFA-1 stimulated cells was not detected when these cells were pre-treated with pY-pept (Fig 7C) . These data suggest that STAT3 competitively binds to stathmin and thereby inhibits its MT depolymerization activity during T-cell migration.
Taken together, these results demonstrate that STAT3 regulates T-cell migration. Inhibition of STAT3 activity disrupts the microtubule network, interferes with post-translational modifications of tubulin and suppresses microtubule dynamics via its physical association with stathmin, thus affecting the function of this cytoskeletal system in the migratory process. DISCUSSION T-cell migration in response to integrin signalling is a complex, highly coordinated, multistep process involving 1) extension of membrane protrusions at the leading edge, 2) formation of attachment sites to the extracellular matrix at the newly formed cell periphery, 3) cell traction, which might be driven by contraction of the cytoskeleton, and 4) the release of adhesions at the rear portions of the cell (detachment) (42) . These events are regulated by multiple signaling mechanisms, such as kinase and/or phosphatase signaling, small GTPase signaling (i.e. Rho and Rac), and cytoskeletal reorganization (42) . Previously, we have demonstrated that T-cells activated through LFA-1 undergo reorganization of the tubulin cytoskeleton during migration (4, 8) . Further, we demonstrated that disruption of tubulin polymerization process or MT dynamics by known tubulin targeting agents such as paclitaxael (MT stabilizer), nocodazole (MT depolymerizer) or PBOX-15 (a novel tubulin depolymerizing compound) inhibits T-cell migration (34) . Here, we demonstrate that suppression of STAT3 activity impaired MT network resulting in the inhibition of T-cell migration. In addition to the multifunctional role of STAT3 in mediating several biological processes including cell proliferation, differentiation, survival, motility, promoting tumor growth (20, 43, 44) , a role of STAT3 is emerging in cell migration as described in both keratinocytes (23, 26) and mouse embryonic fibroblasts (33) . In this study, we demonstrate involvement of STAT3 in T-cell migration, suggesting possible wider roles for this molecule in the migratory processes.
STAT3 is known to be activated by various cytokines and growth factors such as interleukin-6, epidermal growth factor, and hepatocyte growth factor (22) . In response to external stimuli, STAT3 is recruited from the cytosol to phosphorylated receptors via its Src Homology 2 (SH 2 ) domain. STAT3 molecules then become tyrosine (Tyr-705) within receptor complexes, form dimers and translocate to the nucleus to effect expression of responsive genes (18, 24, 44) . Taking advantage of the STAT3 intracellular localization and phosphorylation status associated with its activation state, we demonstrate that LFA-1 cross-linking can activate STAT3 in T-cells by virtue of nuclear translocation as well as induction of Tyr-705 phosphorylation. Pharmacological inhibition of STAT3 by both AG490 and specific peptide blocked LFA-1 induced migration of Hut78 cells. These observations lead to a consistent conclusion that STAT3 activation is required for T-cell migration either by altering expression and/or activation of proteins involving T-cell migration or through its function as an adaptor molecule. Oligonucleotide gene arrays and quantitative realtime PCR analysis have revealed that STAT3 regulates a common set of genes involved in wound healing and cancer (24) , that are implicated in cell migration, metastasis and remodeling of extracellular matrix including for example ICAM-1, CCL2, CXCL2, EPAS-1, proteases in the cathepsin and SERPIN families such as uPA and its receptor uPAR, PAI-1 etc. (24) . Many of these genes also play a role in the process of T-cell migration and trafficking. Further functional genomic and proteomic studies are required to determine the role of STAT3 in the regulation of genes and proteins involved in T-cell migration.
The adaptor function of STAT3 has also been implicated in the cell migration process. Intracellular signaling of STAT3 in keratinocytes modulates tyrosine phosphorylation of p130 cas (a focal adhesion molecule) affecting cell adhesiveness to the substratum and cell migration in response to growth factor (45) . In endothelial cells, phosphorylation of STAT3 in response to VEGFR stimulation resulted in its nuclear translocation and induction of migration and a dominant negative mutant of STAT3 completely inhibited cell migration (46) . Lastly, an association has been reported between STAT3 and Rho GTPases (47), the later being critically involved in the selective stabilization of MTs in the lamella of crawling cells.
Here, we observed that the suppression of STAT3 activity significantly reduced both the acetylated and the tyrosinated form of α-tubulin. These reversible post-translational modifications of α-tubulin have been implicated in regulating MT stability and functions (48, 49) that influence important biological processes such as cell motility, signaling and homeostasis (13, 48) We further demonstrate a direct interaction between STAT3 and stathmin. Moreover, stathmin associates with tubulin, although no direct association of STAT3 with α-tubulin was observed. Stathmin family proteins are important for appropriate cell cycle progression in many types of eukaryotic cells and promote neurite outgrowth through regulation of MT dynamics in growth cones (30) . A reduced level of stathmintubulin interaction has been described at the leading edge of migrating Xenopus A6 cells (28) . Interestingly, stathmin is highly expressed in many types of cancers and overexpression correlates with abnormal motility and tissue invasion of human sarcomas in vivo (54). Experimental evidence suggests that stathmin MTdepolymerizing activity is negatively regulated by phosphorylation on serine residues, of which S16 plays major role(s) (27) . We and others (55) observed that TCR activation by CD3 crosslinking of T-cells induced stathmin phosphorylation (S16). However, we did not detect stathmin phosphorylation (S16) due to LFA-1 cross-linking to Hut78 cells. These suggest that LFA-1 regulation of stathmin is different from that of TCR. Further, we show that TCR induced phosphorylation of stathmin is independent on STAT3, as inhibition of STAT3 activity by pYpept did not affect anti-CD3 stimulated stathmin phosphorylation (S16).
Our results are in agreement with a recent report that STAT3 interacts with stathmin and regulate MT dynamics by antagonizing its depolymerization activity (33) . However, these authors utilized exogenous expression of wild-type or mutant STAT3 and stathmin proteins. Moreover, they demonstrated by cell-free in vitro experiments that STAT3 attenuated stathmin's MT destabilizing activity (33) . Here, we demonstrate a functional involvement of endogenous STAT3 by direct interaction with stathmin to control MT dynamics in migrating T-cells. Specific inhibition of STAT3 activity by pY-pept inhibited stathmin interaction with STAT3 and α-tubulin, thus disrupting its regulation of MT dynamics. It remains to be determined whether STAT3 interacts with other signal-transducing molecules involved in T-cell migration.
Based on our data, we propose a model for STAT3 involvement in regulating T-cell migration (Fig. 8) . LFA-1 cross-linking activates STAT3 by inducing tyrosine phosphorylation and nuclear translocation. The interaction of activated STAT3 with stathmin plays key role(s) in inhibiting the tubulin depolymerization activity of stathmin. This interaction makes tubulin heterodimers available for polymerization during active cytoskeleton reorganization process in migrating T-cells. This presents a novel mechanism through which STAT3 mediates T-cell migration possibly also in combination with its nuclear transcriptional activity.
In conclusion, we have demonstrated that STAT3 is involved in mediating T-cell migration by regulating MT dynamics. The expectation that activated STAT3 would turn on specific transcriptional events and target genes that are integral parts of migrating T-cells forms the basis for further experiments. These studies will greatly enhance the understanding of fundamental intracellular mechanisms involved in T-cell migration. Our results suggest that STAT3 may be potentially used as therapeutic target for various pathological conditions involving T-cell responses including chronic inflammatory disease such as inflammatory bowel disease and the inflammatory arthropathies. Serum starved Hut78 cells were pretreated with 25 µg/ml non-specific peptide Antp or 25 µg/ml STAT3 inhibitory peptide pY-pept for 4 h and incubated on anti-LFA-1 or anti-CD3 coated 6-well plates for 10 min and lysed. Cell lysates (20 µg each) were resolved by SDS-PAGE, and after western blotting probed with anti-phospho stathmin (S16; pStathmin) or anti-stathmin antibody. Relative densitometric analysis of the individual pStathmin band was performed and presented. Data are mean ± S.E.M. of three independent experiments. *p < 0.05 with respect to control. B-M, Hut78 cells untreated or pretreated with 25 µg/ml STAT3 inhibitory peptide (pY-pept; D, G, J, M) were incubated on poly-L lysine (PLL) or anti-LFA-1 coated Permanox® chamber slides for 10 min. After this time, the medium was carefully removed and cells were fixed in 3% PFA. Cells were immunostained for STAT3, phospho STAT3 (Y705; pSTAT3), stathmin or phosphor stathmin (S16; pStathmin) and visualized by confocal microscopy using a 63X oil immersion lens. 
